Regulatory & Compliance

LifeMD's Collapse: Lessons on Telehealth Fraud and Volatility
Tech & Innovation LifeMD's Collapse: Lessons on Telehealth Fraud and Volatility

The telehealth industry has emerged as a transformative force in healthcare, offering unprecedented access to medical services through digital platforms, yet the spectacular downfall of LifeMD, Inc. (NASDALFMD) exposes the sector's vulnerabilities in a way that demands attention. This company, once

FDA Approves Ajovy for Pediatric Migraine Prevention
Management & Regulatory FDA Approves Ajovy for Pediatric Migraine Prevention

Imagine a child unable to attend school or play with friends due to the throbbing pain of a migraine, a condition often dismissed as just a headache but capable of derailing young lives with symptoms like nausea and sensitivity to light. This debilitating neurological disorder affects roughly one

Patient Safety Crisis Persists at Saint Vincent Hospital
Research & Development Patient Safety Crisis Persists at Saint Vincent Hospital

In a troubling development for healthcare in Worcester, Massachusetts, Saint Vincent Hospital, operated by a prominent for-profit hospital system based in Texas, continues to grapple with severe patient safety issues that have sparked widespread concern among staff and regulators alike. Nurses and

How Does Avtozma IV Expand Treatment for Cytokine Release?
Management & Regulatory How Does Avtozma IV Expand Treatment for Cytokine Release?

Imagine a healthcare landscape where life-threatening conditions like cytokine release syndrome (CRS), triggered by immunotherapies or severe infections, can be managed with greater affordability and access. This vision is becoming a reality with the recent FDA approval of Celltrion’s Avtozma IV, a

Can Hernexeos Redefine HER2-Mutant Lung Cancer Treatment?
Management & Regulatory Can Hernexeos Redefine HER2-Mutant Lung Cancer Treatment?

What if a rare and deadly form of lung cancer, long considered a near-hopeless battle, suddenly had a new weapon in its fight? Picture a patient, grappling with the weight of a diagnosis of HER2-mutant non-small cell lung cancer (NSCLC), now finding a glimmer of possibility with an oral therapy

How Is BICO Group AB Positioning for Biopharma Growth?
Tech & Innovation How Is BICO Group AB Positioning for Biopharma Growth?

In the fast-evolving world of biopharma manufacturing, where innovation meets urgent medical needs, BICO Group AB stands as a pivotal player with a sharp focus on lab automation and supply chain solutions. The biopharma sector, particularly the realm of cell and gene therapies (CGTs), is on a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later